NO20092362L - 2-N- (5 - [{4- (2- (methyl-2-pyridinylamino) ethoxy] phenyl] methyl} 2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate - Google Patents

2-N- (5 - [{4- (2- (methyl-2-pyridinylamino) ethoxy] phenyl] methyl} 2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Info

Publication number
NO20092362L
NO20092362L NO20092362A NO20092362A NO20092362L NO 20092362 L NO20092362 L NO 20092362L NO 20092362 A NO20092362 A NO 20092362A NO 20092362 A NO20092362 A NO 20092362A NO 20092362 L NO20092362 L NO 20092362L
Authority
NO
Norway
Prior art keywords
methyl
methods
pyridinylamino
thiazolidinedione
ethoxy
Prior art date
Application number
NO20092362A
Other languages
Norwegian (no)
Inventor
Minutza Leibovici
Yehudit Dolitzky
Yoseph Avezov
Dina Spivak
Ben-Zion Solomon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20092362L publication Critical patent/NO20092362L/en
Application filed by Teva Pharma filed Critical Teva Pharma

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Beskrevet er en isolert forbindelse med formelen (I) sammen med fremgangsmåter for å detektere den og for å minimalisere den i forbedrede farmasøytiske sammensetninger av rosiglitazon maleat.Described is an isolated compound of formula (I) together with methods for detecting it and for minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.

NO20092362A 2006-05-09 2009-06-19 2-N- (5 - [{4- (2- (methyl-2-pyridinylamino) ethoxy] phenyl] methyl} 2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate NO20092362L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/017994 WO2007130064A1 (en) 2006-05-09 2006-05-09 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Publications (1)

Publication Number Publication Date
NO20092362L true NO20092362L (en) 2009-02-04

Family

ID=38668055

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20085124A NO20085124L (en) 2006-05-09 2008-12-09 2-n - (- 5 - [[4- (2- (methyl-2-pyridinylamino) ethoxy] phenly] methyl] -2,4-thaizolidinedione) butanedioic acid, methods of preparation and compositions whit rosiglitazone
NO20092362A NO20092362L (en) 2006-05-09 2009-06-19 2-N- (5 - [{4- (2- (methyl-2-pyridinylamino) ethoxy] phenyl] methyl} 2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20085124A NO20085124L (en) 2006-05-09 2008-12-09 2-n - (- 5 - [[4- (2- (methyl-2-pyridinylamino) ethoxy] phenly] methyl] -2,4-thaizolidinedione) butanedioic acid, methods of preparation and compositions whit rosiglitazone

Country Status (8)

Country Link
JP (1) JP2009536643A (en)
CN (1) CN101426789A (en)
BR (1) BRPI0621551A2 (en)
CA (1) CA2647829A1 (en)
IL (2) IL188175A0 (en)
MX (1) MX2008014298A (en)
NO (2) NO20085124L (en)
WO (1) WO2007130064A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010013141A2 (en) * 2008-08-01 2010-02-04 Actavis Group Ptc Ehf Substantially pure rosiglitazone hydrogen sulfate
CN102863436B (en) * 2012-06-19 2018-02-09 重庆医科大学 Tetrahydrothiazole diketone derivatives and its preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
MX2008014298A (en) 2008-11-26
JP2009536643A (en) 2009-10-15
WO2007130064A1 (en) 2007-11-15
IL199822A0 (en) 2011-07-31
BRPI0621551A2 (en) 2016-08-16
NO20085124L (en) 2009-02-04
WO2007130064A8 (en) 2008-11-13
CA2647829A1 (en) 2007-11-15
IL188175A0 (en) 2008-03-20
CN101426789A (en) 2009-05-06

Similar Documents

Publication Publication Date Title
CL2008002142A1 (en) Compounds derived from 2-amino-6 - ({[2- (4-chlorophenyl) -1,3-thiazol-4-yl] methyl} thio) -4- [4- (2-hydroxyethoxy) phenyl] pyridin-3 , 5-dicarbonitrile; preparation procedure; Pharmaceutical composition and use in cardiovascular diseases.
JP2006512357A5 (en)
CO6160231A2 (en) 5-SUBSTITUTED ISOINDOLINE COMPOUNDS
NZ589962A (en) Inhibitors of stearoyl-CoA desaturase and uses thereof
RS54607B1 (en) 5-substituted quinazolinone derivatives as anti-cancer agents
RU2008117170A (en) PYRIMIDINAMIDE COMPOUNDS AS PGDS INHIBITORS
NO20024307L (en) Hydrochloride salts of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
TW200700416A (en) 'n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
RU2010142229A (en) Cyclopentylacrylamide Derivative
EA200701680A1 (en) DRUG FORM FOR ORAL ADMINISTRATION, CONTAINING ROSIGLITAZONE
NO20015147L (en) Polymorph of 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2,4-dione, maleic acid salt
NO20092362L (en) 2-N- (5 - [{4- (2- (methyl-2-pyridinylamino) ethoxy] phenyl] methyl} 2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
PE20091617A1 (en) TIAZOLIL-DIHIDRO-INDAZOLES
MY148438A (en) Solid forms of a raf kinase inhibitor
JP2013507397A5 (en)
EA200802245A1 (en) METHOD OF OBTAINING 5- {2- [4- (1,2-BENZIZOTIAZOL-3-IL) -1-PIPERASINYL] ETHYL} -6-HLOR-1,3-DIGIDRO-2H-INDOL-2-SHE (CYPRESIDONE)
PL1694646T3 (en) Process for the synthesis of pioglitazone hydrogen chloride
WO2010013768A1 (en) Crystal of thiazolidinedione compound, and process for production thereof
WO2008062244A8 (en) Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
CY2200159T2 (en) 2-N-{5-[[4-[2-METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-2-4-THIAZOLIDINODIONE} BUTANIODIOIC ACID, PREPARATION METHODS AND COMPOSITIONS WITH ROSIGLITAZONE MELEINE
DE60212434D1 (en) ROSIGLITAZONE EDISYLATES AND THEIR USE AS ANTIDIABETICS
EA200700568A1 (en) METHOD OF OBTAINING ROSIGGITAZONE
DE60124119D1 (en) A THIAZOLIDE INDION DERIVATIVE AND ITS USE AS ANTIDIBLE
EA200300231A1 (en) TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA
DE60115062D1 (en) A THIAZOLIDE INDION DERIVATIVE AND ITS USE AS ANTIDIBLE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application